Biểu đồ giá cổ phiếu AKESF
AKESF Dự đoán giá cổ phiếu
Akeso, Inc.
$11.13
-8.3%
$-1
Khi đóng cửa: Sep 02, 16:00:00 GMT-4
$11.5
3.32%
$0.36
Phiên sau giờ: Sep 02, 19:59:40 GMT-4
Quay lại
Akeso, Inc. (AKESF) Dự đoán giá cổ phiếu
Thống kê chính
Giá đóng cửa trước
$12.13
Giá mở cửa
$11.5
Phạm vi ngày
$11.19 - $11.5
Phạm vi 52 tuần
$10.5 - $21.35
Khối lượng
300
Khối lượng trung bình
1.5K
Tỷ suất cổ tức
--
EPS (TTM)
-0.16
Vốn hóa thị trường
$10.5B
AKESO INC. là gì?
Akeso, Inc. Is an investment company, which engages in the research and development, production, and sale of biopharmaceuticals products. The company employs 3,761 full-time employees The company went IPO on 2020-04-24. The Company’s programs covering the therapeutic areas of oncology, autoimmune and metabolic diseases. The firm's products mainly include cadonilimab (PD-1/CTLA-4), ivonescimab (PD-1/VEGF), Ligufalimab (AK117, CD47), Pulocimab (AK109, VEGFR-2), ANNIKO (penpulimab, PD-1), and tagitanlimab (PD-L1) used in oncology fields as well as ebronucimab (PCSK9), ebdarokimab (IL-12/IL-23), and Gumokimab (AK111, IL-17) used in metabolic and autoimmune therapeutic fields.
